Stock listing
4503 Stock Price, News, Filings & Events — Astellas Pharma Inc.
Selected listing: 4503 · TSE · JPY · JP
This page tracks Astellas Pharma Inc.'s 4503:TSE listing on TSE in JPY for JP, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4503:TSE. 4503:TSE is the stock-level entry point for investors researching Astellas Pharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Astellas Pharma Inc. is a public company listed on the Tokyo Stock Exchange under the ticker 4503. Based in Japan, the company has a market capitalization of approximately 23.7 billion USD. Astellas focuses on the development and commercialization of innovative pharmaceutical products.
- Ticker
- 4503:TSE
- Asset type
- Stock
- Market cap
- $27.37B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSE
- Currency
- JPY
Astellas Pharma Inc. 4503:TSE stock context
This page tracks Astellas Pharma Inc.'s 4503:TSE listing on TSE in JPY for JP, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4503:TSE. 4503:TSE is the stock-level entry point for investors researching Astellas Pharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Astellas Pharma Inc. is a public company listed on the Tokyo Stock Exchange under the ticker 4503. Based in Japan, the company has a market capitalization of approximately 23.7 billion USD. Astellas focuses on the development and commercialization of innovative pharmaceutical products.
Latest news from Astellas Pharma Inc.
Astellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastati...
August 24, 2026
Financial Results (Q1 YTD/FY2026)
August 5, 2026
U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin...
July 10, 2026
Ono Pharmaceutical : Pharma Submits a Supplemental Application in Japan to Expand the Use of OPDIVO for the Treatment of Unresectable Ana...
June 11, 2026
Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable G...
May 26, 2026
Astellas Pharma Inc. earnings calls
Astellas Pharma Inc (ALPMF) Q4 2025 Earnings Call
April 27, 2026 · Replay with transcript and chapters
Astellas Pharma Inc (ALPMF) Q3 2025 Earnings Call
February 6, 2026 · Replay with transcript and chapters
Astellas Pharma Inc (ALPMF) Q2 2025 Earnings Call
October 30, 2025 · Replay with transcript and chapters
Astellas Pharma Inc (ALPMF) Q1 2025 Earnings Call
July 30, 2025 · Replay with transcript and chapters
Astellas Pharma Inc (ALPMF) Q4 2024 Earnings Call
April 25, 2025 · Replay with transcript and chapters
Astellas Pharma Inc (ALPMF) Q3 2024 Earnings Call
February 4, 2025 · Replay with transcript and chapters
Research Astellas Pharma Inc.
Astellas Pharma Inc. investor report
Review AI stock analysis and investor report context for 4503:TSE.
Astellas Pharma Inc. company profile
View the public company page for Astellas Pharma Inc. on 6ix.
Astellas Pharma Inc. news
Read company news and market updates connected to Astellas Pharma Inc..
Astellas Pharma Inc. investor events
Find investor webinars, events, and replay context for Astellas Pharma Inc..
Alternate listings
ALPMY:OTC
US · USD
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
ALPMF:OTC
US · USD
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
YPH:GETTEX
DE · EUR
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
YPH:TRADEGATE
DE · EUR
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
856273:LSX
DE · EUR
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
YPH:FWB
DE · EUR
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
856273:LS
DE · EUR
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
4503N:BMV
MX · MXN
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
YPH:SWB
DE · EUR
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
YPH:DUS
DE · EUR
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
4503N:BIVA
MX · MXN
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.
YPH:MUN
DE · EUR
Alternate listing for Astellas Pharma Inc.; the primary context on this page is 4503:TSE.